Guoqiang Yan

502 total citations
25 papers, 382 citations indexed

About

Guoqiang Yan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Guoqiang Yan has authored 25 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Guoqiang Yan's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Guoqiang Yan is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Guoqiang Yan collaborates with scholars based in China. Guoqiang Yan's co-authors include Shiquan Li, Chenyao Li, Yue Meng, Lei Wang, Lei Wang, Tao Liu, Xu Wang, Chao Li, Wei Liu and Tao Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Experimental Cell Research.

In The Last Decade

Guoqiang Yan

24 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoqiang Yan China 13 235 132 75 65 51 25 382
Elena Navarro‐Villarán Spain 10 224 1.0× 101 0.8× 42 0.6× 70 1.1× 56 1.1× 17 397
Qiuju Fan China 11 279 1.2× 104 0.8× 67 0.9× 64 1.0× 61 1.2× 17 387
Chien-Yu Chen United States 5 314 1.3× 157 1.2× 86 1.1× 39 0.6× 60 1.2× 7 475
Yizhi Cao China 12 298 1.3× 180 1.4× 45 0.6× 48 0.7× 37 0.7× 24 420
Deven Patel United States 8 228 1.0× 142 1.1× 62 0.8× 34 0.5× 31 0.6× 8 352
Shenghui Qin China 12 297 1.3× 156 1.2× 108 1.4× 56 0.9× 37 0.7× 27 476
Mika Shimamura Japan 12 216 0.9× 96 0.7× 142 1.9× 39 0.6× 48 0.9× 27 410
Tianwei Chen China 11 247 1.1× 133 1.0× 87 1.2× 39 0.6× 55 1.1× 25 421

Countries citing papers authored by Guoqiang Yan

Since Specialization
Citations

This map shows the geographic impact of Guoqiang Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoqiang Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoqiang Yan more than expected).

Fields of papers citing papers by Guoqiang Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoqiang Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoqiang Yan. The network helps show where Guoqiang Yan may publish in the future.

Co-authorship network of co-authors of Guoqiang Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Guoqiang Yan. A scholar is included among the top collaborators of Guoqiang Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoqiang Yan. Guoqiang Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shaodong, et al.. (2025). Global trends in tumor-associated neutrophil research: a bibliometric and visual analysis. Frontiers in Immunology. 16. 1478092–1478092. 1 indexed citations
2.
Chen, Xu, Xiaohua Wei, Shaofeng Xiong, et al.. (2025). Punicalin ameliorates vascular endothelial cell pyroptosis and dysfunction induced by hyperlipidemia and hyperglycemia through activation of PPARγ. International Immunopharmacology. 165. 115389–115389. 1 indexed citations
4.
Yan, Guoqiang & Lei Wang. (2023). Role of ELK1 in regulating colorectal cancer progression: miR-31-5p/CDIP1 axis in CRC pathogenesis. PeerJ. 11. e15602–e15602. 11 indexed citations
5.
Li, Chenyao, et al.. (2022). MYC-Induced Upregulation of Lncrna ELFN1-AS1 Contributes to Tumor Growth in Colorectal Cancer via Epigenetically Silencing TPM1. Molecular Cancer Research. 20(11). 1697–1708. 11 indexed citations
6.
Meng, Yue, et al.. (2021). LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer. Cancer Cell International. 21(1). 504–504. 18 indexed citations
7.
Meng, Fanqi, et al.. (2021). Engineering of anticancer drugs entrapped polymeric nanoparticles for the treatment of colorectal cancer therapy. Process Biochemistry. 111. 36–42. 11 indexed citations
8.
Li, Shiquan, Guoqiang Yan, Yue Meng, & Lei Wang. (2021). Extracellular vesicles-derived microRNA-222 promotes immune escape via interacting with ATF3 to regulate AKT1 transcription in colorectal cancer. BMC Cancer. 21(1). 349–349. 32 indexed citations
9.
Li, Shiquan, Guoqiang Yan, Wei Liu, Chenyao Li, & Xu Wang. (2020). Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR‐942‐5p and releasing DLG2 via Hippo‐YAP signaling. Molecular Carcinogenesis. 59(12). 1323–1342. 34 indexed citations
10.
Liu, Tao, Chenyao Li, Guoqiang Yan, et al.. (2020). The MRTF-A/miR-155/SOX1 pathway mediates gastric cancer migration and invasion. Cancer Cell International. 20(1). 303–303. 16 indexed citations
11.
Yan, Guoqiang, et al.. (2020). Lysine demethylase 5B suppresses CC chemokine ligand 14 to promote progression of colorectal cancer through the Wnt/β-catenin pathway. Life Sciences. 264. 118726–118726. 14 indexed citations
12.
Li, Chenyao, Chenyao Li, Guoqiang Yan, et al.. (2019). Prognostic roles of microRNA 143 and microRNA 145 in colorectal cancer: A meta-analysis. The International Journal of Biological Markers. 34(1). 6–14. 24 indexed citations
13.
Meng, Yue, et al.. (2018). Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells. Cell Cycle. 17(2). 240–249. 30 indexed citations
14.
Meng, Yue, et al.. (2018). Short- and long-term outcomes of laparoscopic hepatectomy for colorectal liver metastases in elderly patients. Cancer Management and Research. Volume 10. 2581–2587. 6 indexed citations
15.
Yan, Guoqiang, et al.. (2018). Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with colorectal cancer: a meta-analysis. Cellular and Molecular Biology. 64(6). 94–102. 18 indexed citations
17.
18.
Kong, Ying, Guoqiang Yan, Dan Liu, et al.. (2015). Osteopontin-induced brown adipogenesis from white preadipocytes through a PI3K-AKT dependent signaling. Biochemical and Biophysical Research Communications. 459(3). 553–559. 25 indexed citations
19.
Zhao, Pingwei, Guoqiang Yan, Mingxiao Chen, et al.. (2014). The frequency of Th17 and Th22 cells in patients with colorectal cancer at pre-operation and post-operation. Immunological Investigations. 44(1). 56–69. 14 indexed citations
20.
Yan, Guoqiang. (2012). Effect of Radix Dipsaci on Bone Density of Emasculated Rats. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026